ArticleBioinformatics (Oxford, England)2026
Predicting antibody-antigen affinity with a dual-level representation model.
Ziyang Wang, Yu Zhang, Youli Zhang, Jianwei Huang, Xiaoli Lu, Xiaoping Min, Shengxiang Ge, Jun Zhang, Ningshao Xia
Abstract read
In one paragraphArticle in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Youli ZhangState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.
Xiaoli LuInformation and Networking Center, Xiamen University, Xiamen, 361102, China.
Xiaoping MinState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.
Shengxiang GeState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.
Jun ZhangState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.ORCID 0000-0002-6601-9180 Ningshao XiaState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health; National Institute of Diagnostics and Vaccine Development in Infectious Diseases; National Innovation Platform for Industry-Education Integration in Vaccine Research; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, 361102, China.
Funding
Fundamental Research Funds for the Central Universities 20720250004Major Science and Technology Project of Fujian Provincial Health Commission 2021ZD01006National Natural Science Foundation of Chin 62272399National Natural Science Foundation of Chin U24A20742Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0501001
6 · The paper itselfAbstract
motivationProtein language models are critical for modeling antibody-antigen interactions, yet sequence-based affinity prediction remains a key challenge, particularly when structural data are scarce. Existing methods often struggle to fully exploit sequence information, limiting their applicability across diverse antibody formats such as single-domain antibodies (sdAbs).
resultsWe propose dual-level protein representation for affinity prediction (DLP-Affinity), a dual-level deep learning framework for accurate sequence-based affinity prediction. It leverages two complementary modules: residue-to-residue to capture local interface contacts, and global stochastic projection embedding to represent global protein properties. Utilizing a fine-tuned protein language model, our approach achieves state-of-the-art performance on the general AB-Bind dataset (reducing mean absolute error by up to 20.9%) and delivers highly competitive results on the sdAb-DB dataset. This provides a robust tool for sequence-based antibody affinity prediction. AVAILABILITY AND IMPLEMENTATION: The source code and datasets for DLP-Affinity are freely available at https://github.com/Zy-Wang-bit/DLP_Affinity and archived on Zenodo at https://doi.org/10.5281/zenodo.18437656.
Indexed as
AntibodiesAntibody AffinityAntigensComputational BiologyDeep LearningAntibodiesAntigens
Identifiers
PMID41808445
PMCPMC13070686
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390